NDC 72064-125

Ayvakit

Avapritinib

Ayvakit is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Blueprint Medicines Corporation. The primary component is Avapritinib.

Product ID72064-125_5bb10e23-7d74-4b45-86aa-190ef4467b54
NDC72064-125
Product TypeHuman Prescription Drug
Proprietary NameAyvakit
Generic NameAvapritinib
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2020-01-09
Marketing CategoryNDA /
Application NumberNDA212608
Labeler NameBlueprint Medicines Corporation
Substance NameAVAPRITINIB
Active Ingredient Strength25 mg/1
Pharm ClassesKinase Inhibitor [EPC],Tyrosine Kinase Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA],Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA],Bile Salt Export Pump Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 72064-125-30

30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72064-125-30)
Marketing Start Date2020-01-09
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Ayvakit" or generic name "Avapritinib"

NDCBrand NameGeneric Name
72064-110Ayvakitavapritinib
72064-120Ayvakitavapritinib
72064-125Ayvakitavapritinib
72064-130Ayvakitavapritinib
72064-150Ayvakitavapritinib

Trademark Results [Ayvakit]

Mark Image

Registration | Serial
Company
Trademark
Application Date
AYVAKIT
AYVAKIT
88589364 not registered Live/Pending
Blueprint Medicines Corporation
2019-08-22
AYVAKIT
AYVAKIT
88478478 not registered Live/Pending
Blueprint Medicines Corporation
2019-06-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.